Kongming Wu

机构：Shanxi Medical University, Shanxi Academy of Medical Sciences, Tongji Hospital, Huazhong University of Science and Technology · ORCID：0000-0003-2499-1032

发表论文 339 篇 · 总被引 25234 次 · h-index 83

代表论文

• Targeting cytokine and chemokine signaling pathways for cancer therapy (2024 · Signal Transduction and Targeted Therapy · 被引 450)
• Global status and attributable risk factors of breast, cervical, ovarian, and uterine cancers from 1990 to 2021 (2025 · Journal of Hematology & Oncology · 被引 185)
• Optimizing CAR-T cell therapy for solid tumors: current challenges and potential strategies (2024 · Journal of Hematology & Oncology · 被引 106)
• The roles of KRAS in cancer metabolism, tumor microenvironment and clinical therapy (2025 · Molecular Cancer · 被引 82)
• The enhanced antitumor activity of bispecific antibody targeting PD-1/PD-L1 signaling (2024 · Cell Communication and Signaling · 被引 65)
• Tertiary lymphoid structures in cancer: spatiotemporal heterogeneity, immune orchestration, and translational opportunities (2025 · Journal of Hematology & Oncology · 被引 41)